CombiGene AB (publ) Profit Margin

CombiGene AB (publ) (COMBI.ST) currently reports a profit margin of 187.07% as of June 2026. That compares with -1408.62% in the prior-year period — up 113.3% year over year. That is above the sector sector average of 13.16%. Use the charts on this page to explore CombiGene AB (publ)'s profit margin history and peer comparisons.

CombiGene AB (publ)'s profit margin increased from -1408.62% to 187.07% — a 113.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CombiGene AB (publ)'s profit margin of 187.07% is higher than the its sector sector average of 13.16%. That is roughly 1321.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but CombiGene AB (publ)'s current 187.07% should be judged against industry norms (sector average: 13.16%) and against COMBI.ST's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 187.07%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for CombiGene AB (publ), and consider following COMBI.ST for alerts when major investors trade the stock.